Kestra Advisory Services
MDGL icon

Kestra Advisory Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Kestra Advisory Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$654K Sell
1,297
-53
-4% -$28K ﹤0.01% 2278
2026
Q2 		$725K Sell
1,350
-12
-0.9% -$6.15K ﹤0.01% 2049
2026
Q1 		$713K Sell
1,362
-218
-14% -$104K ﹤0.01% 1964
2025
Q4 		$920K Buy
1,580
+13
+0.8% +$6.64K ﹤0.01% 1714
2025
Q3 		$719K Sell
1,567
-98
-6% -$36.6K ﹤0.01% 1821
2025
Q2 		$504K Sell
1,665
-41
-2% -$12.2K ﹤0.01% 1958
2025
Q1 		$565K Buy
1,706
+1
+0.1% +$329 ﹤0.01% 1740
2024
Q4 		$526K Sell
1,705
-909
-35% -$256K ﹤0.01% 1842
2024
Q3 		$555K Buy
2,614
+145
+6% +$37.1K ﹤0.01% 1707
2024
Q2 		$692K Sell
2,469
-115
-4% -$27.4K ﹤0.01% 1559
2024
Q1 		$690K Sell
2,584
-1,020
-28% -$240K ﹤0.01% 1463
2023
Q4 		$834K Sell
3,604
-2
-0.1% -$350 0.01% 1220
2023
Q3 		$527K Buy
3,606
+25
+0.7% +$4.7K 0.01% 1344
2023
Q2 		$827K Buy
3,581
+1,021
+40% +$277K 0.01% 1069
2023
Q1 		$620K Buy
2,560
+104
+4% +$28.3K 0.01% 1169
2022
Q4 		$713K Buy
+2,456
New +$240K 0.01% 1212

Other funds holding MDGL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Kestra Advisory Services's MDGL Position: Q3 2026 in Review

Kestra Advisory Services reduced its Madrigal Pharmaceuticals (MDGL) stake by 3.9% in Q3 2026, selling an estimated $28K and leaving 1,297 shares worth $654K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Kestra Advisory Services first reported a position in MDGL in Q4 2022 and has held it in 16 quarters since. The position peaked at $920K in Q4 2025. 181 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Kestra Advisory Services held 1,297 shares of Madrigal Pharmaceuticals worth $654K as of Q3 2026.
  • Kestra Advisory Services sold 53 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $28K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Kestra Advisory Services's portfolio in Q3 2026, its #2278 holding.
  • Kestra Advisory Services first reported a position in Madrigal Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
  • Kestra Advisory Services's Madrigal Pharmaceuticals position peaked at $920K in Q4 2025.
  • 181 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Kestra Advisory Services's 13F filing for Q3 2026, filed 2 Nov 2026.